PL2612926T3 - Metody wykorzystania mirna do wykrywania śmierci komórkowej in vivo - Google Patents

Metody wykorzystania mirna do wykrywania śmierci komórkowej in vivo

Info

Publication number
PL2612926T3
PL2612926T3 PL13161985T PL13161985T PL2612926T3 PL 2612926 T3 PL2612926 T3 PL 2612926T3 PL 13161985 T PL13161985 T PL 13161985T PL 13161985 T PL13161985 T PL 13161985T PL 2612926 T3 PL2612926 T3 PL 2612926T3
Authority
PL
Poland
Prior art keywords
mirna
detection
methods
cell death
vivo cell
Prior art date
Application number
PL13161985T
Other languages
English (en)
Inventor
Eugene M. Shekhtman
Hovsep S. Melkonyan
Samuil R. Umansky
Vladimir S. Scheinker
Original Assignee
Trovagene, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40378881&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2612926(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Trovagene, Inc. filed Critical Trovagene, Inc.
Publication of PL2612926T3 publication Critical patent/PL2612926T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL13161985T 2007-08-22 2008-08-22 Metody wykorzystania mirna do wykrywania śmierci komórkowej in vivo PL2612926T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96587107P 2007-08-22 2007-08-22
EP08795523.3A EP2195450B2 (en) 2007-08-22 2008-08-22 Methods of using mirna for detection of in vivo cell death
EP13161985.0A EP2612926B1 (en) 2007-08-22 2008-08-22 Methods of using mirna for detection of in vivo cell death

Publications (1)

Publication Number Publication Date
PL2612926T3 true PL2612926T3 (pl) 2018-07-31

Family

ID=40378881

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13161985T PL2612926T3 (pl) 2007-08-22 2008-08-22 Metody wykorzystania mirna do wykrywania śmierci komórkowej in vivo
PL08795523T PL2195450T3 (pl) 2007-08-22 2008-08-22 Sposób zastosowania miRNA do wykrywania in vivo śmierci komórki

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL08795523T PL2195450T3 (pl) 2007-08-22 2008-08-22 Sposób zastosowania miRNA do wykrywania in vivo śmierci komórki

Country Status (16)

Country Link
US (4) US8486626B2 (pl)
EP (2) EP2612926B1 (pl)
JP (1) JP5416110B2 (pl)
CN (2) CN105400868B (pl)
AU (2) AU2008289447B2 (pl)
CA (1) CA2696403C (pl)
CY (1) CY1114111T1 (pl)
DK (2) DK2195450T4 (pl)
ES (2) ES2415245T5 (pl)
HR (1) HRP20130618T1 (pl)
HU (1) HUE019019T5 (pl)
NO (1) NO2612926T3 (pl)
PL (2) PL2612926T3 (pl)
PT (2) PT2195450E (pl)
TR (1) TR201802758T4 (pl)
WO (1) WO2009025852A2 (pl)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009132273A2 (en) * 2008-04-25 2009-10-29 Merck & Co., Inc. Microrna biomarkers of tissue injury
WO2010004562A2 (en) * 2008-07-09 2010-01-14 Rosetta Genomics Ltd. Methods and compositions for detecting colorectal cancer
ES2595489T3 (es) * 2008-07-18 2016-12-30 Trovagene, Inc. Métodos para la detección de secuencias de ácidos nucleicos "ultracortos" basados en PCR
CA2757711A1 (en) * 2009-04-14 2010-10-21 Merck Sharp & Dohme Corp. Microrna as a biomarker of pancreatic islet beta-cell engagement
US9752191B2 (en) 2009-07-09 2017-09-05 The Scripps Research Institute Gene expression profiles associated with chronic allograft nephropathy
CA2780222C (en) 2009-11-04 2021-11-16 Diamir, Llc Methods of using small rna from bodily fluids for diagnosis and monitoring of neurodegenerative diseases
CA2779750C (en) 2009-11-06 2019-03-19 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive diagnosis of graft rejection in organ transplant patients
WO2011143659A2 (en) * 2010-05-14 2011-11-17 Fluidigm Corporation Nucleic acid isolation methods
EP3327145A1 (en) * 2011-04-18 2018-05-30 DiamiR, LLC Methods for using mirna from bodily fluids for early detection and monitoring of mild cognitive impairment (mci) and alzheimer s disease (ad)
CN102188719B (zh) * 2011-05-12 2012-12-19 南方医科大学 EB病毒miR-BART3反义寡聚核苷酸在制备治疗鼻咽癌的药物中的应用
KR102082016B1 (ko) 2011-06-27 2020-02-26 에자이 알앤드디 매니지먼트 가부시키가이샤 알츠하이머병을 나타내는 마이크로rna 바이오마커들
EP2742155B1 (en) * 2011-08-08 2018-01-24 Advanced Genomic Technology LLC Biomarker for alzheimer's disease and/or mild cognitively impairment
CA3069089A1 (en) * 2011-09-22 2013-03-28 Lineage Biosciences, Inc. Compositions and methods for analyzing heterogeneous samples
ITRM20110685A1 (it) 2011-12-23 2013-06-24 Internat Ct For Genetic En Gineering And Microrna per la rigenerazione cardiaca attraverso l induzione della proliferazione dei miociti cardiaci
US20160289762A1 (en) 2012-01-27 2016-10-06 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiliing and quantitating cell-free rna
EP3584327A1 (en) 2012-01-27 2019-12-25 The Board of Trustees of the Leland Stanford Junior University Methods for profiling and quantitating cell-free rna
US20140087964A1 (en) * 2012-09-24 2014-03-27 University Of Virginia Patent Foundation Compositions and methods for detecting aberrant regulation, expression, and levels of hgh
WO2014075822A1 (en) * 2012-11-16 2014-05-22 Siemens Aktiengesellschaft New diagnostic mirna markers for parkinson disease
EP2733219B1 (en) 2012-11-16 2017-09-20 Siemens Aktiengesellschaft Diagnostic miRNA markers for Alzheimer
EP2733220B1 (en) * 2012-11-16 2017-10-18 Siemens Aktiengesellschaft Novel miRNA as a diagnostic marker for Alzheimer's Disease
CN103045596A (zh) * 2012-12-20 2013-04-17 徐勇 唐氏综合征21号染色体相关miRNA、基因、筛选方法和应用
CN103045736B (zh) * 2012-12-20 2014-09-17 徐勇 唐氏综合征21号染色体miRNA差异表达图谱模型、构建方法及应用
EP2759602A1 (en) 2013-01-25 2014-07-30 Charité - Universitätsmedizin Berlin Non-invasive prenatal genetic diagnostic methods
WO2014144822A2 (en) 2013-03-15 2014-09-18 Immumetrix, Inc. Methods and compositions for tagging and analyzing samples
CA2931082C (en) 2013-11-18 2024-01-23 Diamir, Llc Methods of using mirnas from bodily fluids for detection and monitoring of parkinson's disease (pd)
US10443100B2 (en) 2014-05-22 2019-10-15 The Scripps Research Institute Gene expression profiles associated with sub-clinical kidney transplant rejection
US11104951B2 (en) 2014-05-22 2021-08-31 The Scripps Research Institute Molecular signatures for distinguishing liver transplant rejections or injuries
US11062789B2 (en) 2014-07-18 2021-07-13 The Chinese University Of Hong Kong Methylation pattern analysis of tissues in a DNA mixture
AU2016264102A1 (en) 2015-05-18 2017-12-21 Karius, Inc. Compositions and methods for enriching populations of nucleic acids
WO2017019751A1 (en) 2015-07-27 2017-02-02 The Johns Hopkins University Method to use viral and host methylation markers for cervical cancer screening and triage in liquid prep, serum/plasma, and urine: pcr and sequencing based process methods
WO2017044710A1 (en) * 2015-09-11 2017-03-16 Corning Incorporated Compositions and methods for nucleic acid purification from blood samples
US10975436B2 (en) 2016-01-05 2021-04-13 Diamir, Llc Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurodevelopmental disorders
ES2993025T3 (en) 2016-03-21 2024-12-20 Diamir Llc Methods of using mirnas from bodily fluids for detection and differentiation of neurodegenerative diseases
WO2018045359A1 (en) * 2016-09-02 2018-03-08 Karius, Inc. Detection and treatment of infection during pregnancy
US11001891B2 (en) 2016-11-14 2021-05-11 Berg Llc Methods for treating Parkinson's disease
KR102921023B1 (ko) 2016-11-30 2026-01-30 더 차이니즈 유니버시티 오브 홍콩 소변 및 기타 샘플에서의 무세포 dna의 분석
US10907211B1 (en) 2017-02-16 2021-02-02 Quantgene Inc. Methods and compositions for detecting cancer biomarkers in bodily fluids
US10781487B2 (en) 2017-07-24 2020-09-22 Diamir, Llc miRNA-based methods for detecting and monitoring aging
GB2612911B (en) 2019-02-14 2023-11-22 Mirvie Inc Methods and systems for determining a pregnancy-related state of a subject
CN114449954B (zh) * 2019-10-29 2025-05-02 国立研究开发法人国立循环器病研究中心 脑梗塞治疗辅助系统
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856088A (en) * 1989-07-11 1999-01-05 Gen-Probe Incorporated Detection of human immunodeficiency virus type 1
US5168039A (en) * 1990-09-28 1992-12-01 The Board Of Trustees Of The University Of Arkansas Repetitive DNA sequence specific for mycobacterium tuberculosis to be used for the diagnosis of tuberculosis
US6020124A (en) * 1992-04-27 2000-02-01 Trustees Of Dartmouth College Detection of soluble gene sequences in biological fluids
DK0710248T3 (da) * 1993-07-20 2000-04-10 Roche Diagnostics Gmbh Melanom-inhiberende protein
WO1995004140A1 (en) 1993-07-28 1995-02-09 Akzo Nobel N.V. Process for isolating nucleic acid from gram positive microorganisms
JP3696238B2 (ja) * 1993-08-30 2005-09-14 プロメガ・コーポレイシヨン 核酸精製用組成物及び方法
US5631130A (en) * 1994-05-13 1997-05-20 Abbott Laboratories Materials and methods for the detection of Mycobacterium tuberculosis
JP4558105B2 (ja) * 1994-06-09 2010-10-06 イノジェネティックス・ナムローゼ・フェンノートシャップ ミコバクテリウム種の抗生物質耐性スペクトルの検出方法
US5731150A (en) * 1995-11-01 1998-03-24 Chiron Diagnostic Corporation IS6110 based molecular detection of mycobacterium tuberculosis
US6027945A (en) * 1997-01-21 2000-02-22 Promega Corporation Methods of isolating biological target materials using silica magnetic particles
WO1998054364A1 (en) * 1997-05-30 1998-12-03 Lxr Biotechnology Inc. Methods for detection of nucleic acid sequences in urine
US6492144B1 (en) * 1997-05-30 2002-12-10 Diagen Corporation Methods for detection of nucleic acid sequences in urine
US20020119478A1 (en) * 1997-05-30 2002-08-29 Diagen Corporation Methods for detection of nucleic acid sequences in urine
US5962665A (en) 1997-06-16 1999-10-05 Abbott Laboratories Nucleic acid primers and probes for detecting HIV-1 and HIV-2
US20060204989A1 (en) * 1998-09-22 2006-09-14 Kopreski Michael S Comparative analysis of extracellular RNA species
US7196183B2 (en) * 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US20040053264A1 (en) * 2002-02-01 2004-03-18 Park Sung Sup Clinical panel assay using DNA chips
EP2290072B1 (en) * 2004-05-28 2014-12-17 Asuragen, Inc. Methods and compositions involving microRNA
ITRM20050068A1 (it) * 2005-02-17 2006-08-18 Istituto Naz Per Le Malattie I Metodo per la rivelazione di acidi nucleici di agenti patogeni batterici o di parassiti nelle urine.
US7914982B2 (en) * 2005-02-17 2011-03-29 Trovagene, Inc. Methods for detecting pathogen specific nucleic acids in urine
EP1885877A2 (en) 2005-02-17 2008-02-13 Istituto Nazionale per le Malattie Infettive "Lazzaro Spallanzani" IRCCS Compositions and methods for detecting pathogen specific nucleic acids in urine
ITRM20050067A1 (it) * 2005-02-17 2006-08-18 Istituto Naz Per Le Malattie I Metodo per la rivelazione di acidi nucleici virali o di origine virale nelle urine.
AU2006214096B2 (en) 2005-02-17 2011-06-16 Trovagene, Inc. Compositions and methods for detecting viral specific nucleic acids in urine
US20060292616A1 (en) * 2005-06-23 2006-12-28 U.S. Genomics, Inc. Single molecule miRNA-based disease diagnostic methods
DE102005059315A1 (de) * 2005-12-09 2007-06-14 Qiagen Gmbh Verfahren zur Anreicherung von kurzkettigen Nukleinsäuren
US20070202511A1 (en) * 2006-02-28 2007-08-30 Sigma-Aldrich Co. Methods and compositions for the rapid isolation of small RNA molecules
ES2595489T3 (es) * 2008-07-18 2016-12-30 Trovagene, Inc. Métodos para la detección de secuencias de ácidos nucleicos "ultracortos" basados en PCR

Also Published As

Publication number Publication date
PT2195450E (pt) 2013-07-10
HUE019019T5 (en) 2017-04-28
JP2010536372A (ja) 2010-12-02
TR201802758T4 (tr) 2018-03-21
HK1218767A1 (zh) 2017-03-10
US20090081640A1 (en) 2009-03-26
CA2696403A1 (en) 2009-02-26
WO2009025852A3 (en) 2009-05-07
NO2612926T3 (pl) 2018-04-28
US20180135126A1 (en) 2018-05-17
JP5416110B2 (ja) 2014-02-12
CN105400868A (zh) 2016-03-16
US8486626B2 (en) 2013-07-16
AU2014210676B2 (en) 2017-04-06
EP2612926A1 (en) 2013-07-10
DK2195450T4 (en) 2016-10-24
DK2195450T3 (da) 2013-06-24
AU2014210676A1 (en) 2014-08-28
EP2195450B2 (en) 2016-07-20
EP2612926B1 (en) 2017-11-29
US20200283851A1 (en) 2020-09-10
DK2612926T3 (en) 2018-03-12
EP2195450B1 (en) 2013-04-03
EP2195450A2 (en) 2010-06-16
PT2612926T (pt) 2018-03-02
CN101861399B (zh) 2015-11-25
ES2415245T5 (es) 2016-12-23
PL2195450T3 (pl) 2013-09-30
HRP20130618T1 (en) 2013-07-31
US20150197805A1 (en) 2015-07-16
CA2696403C (en) 2018-01-02
ES2415245T3 (es) 2013-07-24
CN105400868B (zh) 2021-03-26
ES2660785T3 (es) 2018-03-26
AU2008289447A1 (en) 2009-02-26
CN101861399A (zh) 2010-10-13
AU2008289447B2 (en) 2014-09-04
CY1114111T1 (el) 2016-07-27
WO2009025852A2 (en) 2009-02-26

Similar Documents

Publication Publication Date Title
PL2612926T3 (pl) Metody wykorzystania mirna do wykrywania śmierci komórkowej in vivo
IL301475B1 (en) Laboratory methods for increasing the vitality of immune system cells
ZA201008391B (en) Pluripotent cells
EP2430446A4 (en) METHOD AND COMPOSITIONS FOR DETECTING ANALYTES
IL217871A0 (en) Method for in vivo expansion of t regulatory cells
SG10201405455UA (en) Cells and methods for obtaining them
EP2493494A4 (en) METHODS AND NECESSARY TO PREVENT HYPOGLYCEMIA
EP2334814A4 (en) METHODS AND COMPOSITIONS FOR DIRECT DETECTION OF DNA INJURIES
EP2245686A4 (en) COVERS FOR ELECTROCHEMICAL CELLS AND RELATED METHODS
GB0801479D0 (en) Improvements to methods of in field analysis
GB0800524D0 (en) Cell culture system
EP2483391A4 (en) PROCESS AND KITS FOR THE RELEASE OF CELLS
PL2317294T3 (pl) Komórka pomiarowa
GB0817990D0 (en) Cell culture vessel
ZA201007010B (en) Rapid detection of mycobateria
EP2121042A4 (en) COMPOUNDS AND METHOD FOR THE DETECTION OF CELLS
GB0921712D0 (en) Methods of detecting DNA damage
GB0919520D0 (en) Quantifying cell death
TWI369495B (en) Cell detecting method
EP2357472A4 (en) METHOD FOR EVALUATING CELL STATUS
SI2195450T1 (sl) Postopki za uporabo miRNA za detekcijo celične smrti in vivo
EP2478113A4 (en) COMPOSITIONS AND METHODS FOR EVALUATING BIOLUMINESCENCE IN VIVO
EP2130915A4 (en) CELL THAT CAN EXPRESS A LARGE QUANTITY OF LACRITIN
EP2318570A4 (en) ELECTROLYTIC CELL AND RELATED METHODS FOR THE PRODUCTION AND USE THEREOF
GB2457481B (en) Fluorescence measurement cell